Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

NCT00123318 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.

NCT NCT00123318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Lead sponsor
Trans Tasman Radiation Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
February 29, 2012
Enrollment
52 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer